CAG
37
-3
D
38
-5
VIX
49
6
CF
38
2
CA
42
12
CTAS
39
-3
CVS
41
-2
AXP
64
-2
BMY
71
-3
CNP
55
-4
AIZ
73
-3
BXP
38
-3
AON
63
-2
AMT
29
-4
CMA
59
-2
AAPL
53
-2
ACN
47
-7
APH
52
-4
CTSH
54
-3
CSCO
58
-2
CAG
37
-3
D
38
-5
VIX
49
6
CF
38
2
CA
42
12
CTAS
39
-3
CVS
41
-2
AXP
64
-2
BMY
71
-3
CNP
55
-4
AIZ
73
-3
BXP
38
-3
AON
63
-2
AMT
29
-4
CMA
59
-2
AAPL
53
-2
ACN
47
-7
APH
52
-4
CTSH
54
-3
CSCO
58
-2
Financhill
Back

Pliant Therapeutics, Inc. Vs. Rapt Therapeutics, Inc. Industry Stock Comparison

Sell
17

PLRX
Pliant Therapeutics, Inc.

Last Price:
$1.21
Seasonality Move:
-12.32%
Sell
38

RAPT
Rapt Therapeutics, Inc.

Last Price:
$33.91
Seasonality Move:
-28.15%
Sell
17
Pliant Therapeutics, Inc. (PLRX) is a Sell

Is Pliant Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Pliant Therapeutics, Inc. [PLRX] share price is $1.22. The Score for PLRX is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • PLRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
38
Rapt Therapeutics, Inc. (RAPT) is a Sell

Is Rapt Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Rapt Therapeutics, Inc. [RAPT] share price is $33.87. The Score for RAPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • RAPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PLRX Stock Price Chart

What is Pliant Therapeutics, Inc.'s stock price today?

  • The Pliant Therapeutics, Inc. share price today is $1.22
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLRX is experiencing slight selling pressure.

RAPT Stock Price Chart

What is Rapt Therapeutics, Inc.'s stock price today?

  • The Rapt Therapeutics, Inc. share price today is $33.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAPT is experiencing slight buying pressure.

PLRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.34 Buy
Relative Strength Index (14 RSI): 38.64 Sell
Chaikin Money Flow: -208138 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.18 - 1.46) Sell
Bollinger Bands (100): (1.36 - 1.7) Sell

RAPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.53 Buy
Relative Strength Index (14 RSI): 51.15 Buy
Chaikin Money Flow: 79100 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.58 - 35.84) Sell
Bollinger Bands (100): (16.83 - 33.91) Buy

PLRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.22 Sell
20-day SMA: 1.26 Sell
50-day SMA: 1.49 Sell
200-day SMA: 1.48 Sell
8-day EMA: 1.12 Buy
20-day EMA: 0.77 Buy
50-day EMA: 0.4 Buy
200-day EMA: 0.12 Buy

RAPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35 Sell
20-day SMA: 34.72 Sell
50-day SMA: 31.71 Buy
200-day SMA: 17.02 Buy
8-day EMA: 31.84 Buy
20-day EMA: 21.97 Buy
50-day EMA: 11.45 Buy
200-day EMA: 3.3 Buy

Pliant Therapeutics, Inc. Earnings Growth & PLRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.59 per share, and an increase next year of $0.36 per share.

Rapt Therapeutics, Inc. Earnings Growth & RAPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.65 per share, and a decrease next year of $1.22 per share.

Pliant Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rapt Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):